OBJECTIVE: Remifentanil (RF) is a potent short-acting μ-opioid receptor agonist. Although preferred for its unique pharmacokinetics, the clinical use may be limited by hyperalgesia. Preclinical studies have shown a potential role of microglia on the development of hyperalgesia, with limited and conflicting evidence on RF. Considering the role of microglia in the initiation and maintenance of brain inflammation and their different responses among species, we aimed at characterizing RF effects on human adult microglia in vitro. MATERIALS AND METHODS: RF was tested at clinically relevant concentrations on the human microglial C20 cell line. Expression and release of interleukin-6 (IL-6) and brain derived neurotrophic factor (BDNF) were assessed under basal and inflammatory conditions. RESULTS: The expression and secretion of IL-6 significantly increased in C20 cells in response to pro-inflammatory cytokines. RF did not modify this response neither under basal nor under inflammatory conditions. No toxicity due to RF was detected. The drug displayed a modest stimulatory effect on the production of BDNF. CONCLUSIONS: Although RF does not exert direct pro-inflammatory actions on human adult microglia, its effects on BDNF, a crucial mediator of pain transmission, suggest a possible role on neuroinflammation and pain perception.

Cappoli, N., Aceto, P., Tabolacci, E., Mezzogori, D., Sollazzi, L., Navarra, P., Dello Russo, C., Effects of remifentanil on human C20 microglial pro-inflammatory activation, <<EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES>>, 2021; 25 (16): 5268-5274. [doi:10.26355/eurrev_202108_26547] [http://hdl.handle.net/10807/193277]

Effects of remifentanil on human C20 microglial pro-inflammatory activation

Cappoli, Natalia;Aceto, Paola
;
Tabolacci, Elisabetta;Sollazzi, Liliana;Navarra, Pierluigi;Dello Russo, Cinzia
2021

Abstract

OBJECTIVE: Remifentanil (RF) is a potent short-acting μ-opioid receptor agonist. Although preferred for its unique pharmacokinetics, the clinical use may be limited by hyperalgesia. Preclinical studies have shown a potential role of microglia on the development of hyperalgesia, with limited and conflicting evidence on RF. Considering the role of microglia in the initiation and maintenance of brain inflammation and their different responses among species, we aimed at characterizing RF effects on human adult microglia in vitro. MATERIALS AND METHODS: RF was tested at clinically relevant concentrations on the human microglial C20 cell line. Expression and release of interleukin-6 (IL-6) and brain derived neurotrophic factor (BDNF) were assessed under basal and inflammatory conditions. RESULTS: The expression and secretion of IL-6 significantly increased in C20 cells in response to pro-inflammatory cytokines. RF did not modify this response neither under basal nor under inflammatory conditions. No toxicity due to RF was detected. The drug displayed a modest stimulatory effect on the production of BDNF. CONCLUSIONS: Although RF does not exert direct pro-inflammatory actions on human adult microglia, its effects on BDNF, a crucial mediator of pain transmission, suggest a possible role on neuroinflammation and pain perception.
2021
Inglese
Cappoli, N., Aceto, P., Tabolacci, E., Mezzogori, D., Sollazzi, L., Navarra, P., Dello Russo, C., Effects of remifentanil on human C20 microglial pro-inflammatory activation, <<EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES>>, 2021; 25 (16): 5268-5274. [doi:10.26355/eurrev_202108_26547] [http://hdl.handle.net/10807/193277]
File in questo prodotto:
File Dimensione Formato  
2021 Cappoli N et al. Eur Rev Med Pharm Sci.pdf

accesso aperto

Descrizione: Articolo pubblicato come open access
Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 562.98 kB
Formato Adobe PDF
562.98 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/193277
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 0
social impact